At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 40 enrolled
Drug / intervention
Platelet Rich Plasma +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Platelet Rich Plasma (PRP) Application on Rotator Cuff Tear.
In Brief
A Phase 1 clinical trial evaluating Platelet Rich Plasma and Normal saline for Tendon Injuries and 2 related conditions. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The aim of this randomized control trial is to evaluate the impact and effectiveness of PRP on tenocyte metabolism and tendon tissue properties in rotator cuff tear.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTendon Injuries, Supraspinatus Injury, PRP
CountriesGreece
Collaborators--
Timeline
Phase 1CompletedFinished
2023202420252026
Enrollment StartDec 2022
Primary CompletionJan 2026
Study CompletionJan 2026
First PostedMar 2026
TodayJul 2026
First PostedMar 6, 2026
Enrollment StartDec 23, 2022
Primary CompletionJan 13, 2026
Study CompletionJan 14, 2026
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 4 months ago
Interventions
Platelet Rich Plasmabiological
The injection of PRP in the subacromial space.
Normal salineother
The injection of normal saline in the subacromial space.